Latest Ratios: P/E Ratio -0.2x · EV/EBITDA N/A · ROE -204.4%. (2015–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $244689 | $4M | $4M | $2M | $4M | $17M | $40M | $5M | $7M | $12M | — |
| Enterprise Value | $-4532238 | $-444764 | $-1892952 | $-12210184 | $-12861474 | $-8052334 | $3M | $2M | $4M | $2M | — |
| P/E Ratio → | -0.16 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.61 | 10.88 | 8.32 | 3.61 | 7.83 | 144.09 | — | — | — | — | — |
| P/B Ratio | 0.37 | 0.85 | 0.54 | 0.11 | 0.15 | 0.36 | 0.85 | 0.31 | 0.29 | 0.48 | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | -1.12 | -4.34 | -24.57 | -23.38 | -67.10 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.8% | 64.8% | 60.6% | 71.2% | 54.2% | 44.2% | — | — | — | — | — |
| Operating Margin | -3060.6% | -3060.6% | -2907.3% | -3277.9% | -3173.6% | -13287.5% | — | — | — | — | — |
| Net Profit Margin | -3041.0% | -3041.0% | -2554.6% | -3704.2% | -3941.1% | -12530.0% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -204.4% | -204.4% | -98.0% | -82.2% | -56.0% | -31.4% | -47.8% | -75.3% | -60.6% | -109.3% | -658.5% |
| ROA | -133.8% | -133.8% | -76.7% | -70.5% | -50.2% | -29.1% | -43.7% | -67.9% | -55.4% | -95.9% | -255.9% |
| ROIC | -1184.2% | -1184.2% | -594.2% | -179.6% | -75.0% | -72.7% | -85.6% | -67.7% | -56.1% | -82.1% | -2883.8% |
| ROCE | -170.5% | -170.5% | -100.8% | -68.7% | -43.1% | -32.3% | -39.3% | -73.6% | -52.8% | -56.0% | -279.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.30 | 0.30 | 0.23 | 0.10 | 0.07 | 0.06 | 0.03 | 0.09 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.93 | -0.82 | -0.88 | -0.60 | -0.52 | -0.80 | -0.21 | -0.13 | -0.39 | -0.77 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | -1408.44 | -1629.10 | — | — | — | — | -73.60 | -227.10 | — |
Net cash position: cash ($6M) exceeds total debt ($2M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.30 | 3.30 | 4.50 | 7.92 | 10.38 | 17.14 | 21.92 | 5.25 | 12.78 | 21.51 | 8.52 |
| Quick Ratio | 3.30 | 3.30 | 4.50 | 7.92 | 10.38 | 17.10 | 21.92 | 5.55 | 12.94 | 31.98 | 9.38 |
| Cash Ratio | 3.05 | 3.05 | 4.10 | 7.49 | 10.02 | 16.86 | 21.72 | 4.95 | 12.42 | 21.09 | 8.30 |
| Asset Turnover | — | 0.05 | 0.04 | 0.03 | 0.02 | 0.00 | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | 0.59 | — | — | — | — | — |
| Days Sales Outstanding | — | 339.32 | 302.21 | 508.21 | 306.60 | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $1M | $116620 | $82817 | $80684 | $80643 | $78170 | $38653 | $32975 | $23594 | $16823 |
Existential liquidity and dilution
According to current market data, FRSX trades at a P/S ratio of 0.61, which, when compared to the broader ADAS peer group, suggests investors are assigning minimal value to the company's intellectual property portfolio while pricing in a high probability of further equity dilution to sustain operations.
The depressed P/S multiple indicates that the market has largely discounted the company's ability to scale its current pilot-based revenue model into a high-volume commercial enterprise. This valuation appears to reflect a 'lottery ticket' sentiment where the stock price is driven more by potential IP acquisition interest than by fundamental growth prospects.
As reported in financial statements, the company's ROIC has consistently languished in deep negative territory, reaching -58.4% in 2025Q2, which highlights a structural inability to generate returns on invested capital as R&D spending continues to outpace the limited commercial output of its vision systems.
The persistent decay in ROIC suggests that every dollar of capital deployed into the business is currently destroying shareholder value rather than compounding it. This trend warrants further investigation into whether the company's R&D investments are truly creating proprietary advantages or simply funding the maintenance of a non-commercialized technology stack.
Based on the provided figures, the company's DSO has remained exceptionally high, peaking at 739 days in 2024Q3, which suggests that the firm lacks significant leverage over its customers and faces substantial delays in converting project-based engineering milestones into actual cash inflows.
The extreme length of the cash conversion cycle implies that the company's revenue recognition is tied to long-term, uncertain development milestones rather than standard commercial sales. This inefficiency forces the company to rely on external financing to bridge the gap between project initiation and final payment, increasing its vulnerability to capital market volatility.
According to recent balance sheet disclosures, the current ratio has compressed to 4.02 as of 2025Q2, down from historical highs, signaling that the company's ability to cover short-term obligations is becoming increasingly dependent on its dwindling cash reserves rather than operational cash generation.
While a current ratio of 4.02 appears healthy in isolation, it is misleading given the company's lack of recurring revenue and high cash burn rate. Investors should monitor the liquidity position closely, as the current trajectory suggests that the firm may face a critical funding gap within the next twelve months.
The P/E ratio is the most commonly misapplied metric for this business model, as it obscures the reality of a pre-commercial firm by suggesting that negative earnings are a temporary cyclical issue rather than a structural feature of an R&D-heavy, pre-revenue technology development cycle.
Using P/E to evaluate FRSX is fundamentally flawed because the company is not yet in a phase of earnings generation; instead, analysts should focus on cash burn rates and the conversion of PoCs into design wins. Relying on earnings-based multiples in this context may lead to an incorrect assessment of the company's true financial health and its distance from commercial viability.
Includes 30+ ratios · 11 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FRSX stock.
Foresight Autonomous Holdings Ltd.'s current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
Foresight Autonomous Holdings Ltd.'s return on equity (ROE) is -204.4%. The historical average is -85.0%.
Based on historical data, Foresight Autonomous Holdings Ltd. is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Foresight Autonomous Holdings Ltd. has 64.8% gross margin and -3060.6% operating margin.